サンプル依頼リスト カート
  • English
  • Traditional Chinese
  • Simplified Chinese
表紙：医薬品ロジスティクスの世界市場：2023年～2030年
市場調査レポート
商品コード
1382549

医薬品ロジスティクスの世界市場：2023年～2030年

Global Pharmaceutical Logistics Market - 2023-2030
出版日: | 発行: DataM Intelligence | ページ情報: 英文 187 Pages | 納期: 約2営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
医薬品ロジスティクスの世界市場：2023年～2030年
出版日: 2023年11月17日
発行: DataM Intelligence
ページ情報: 英文 187 Pages
納期: 約2営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 目次
概要

概要

医薬品ロジスティクスは、製造、加工、材料や資源の出荷を扱います。また、製造された商品を顧客に配送する業務も扱います。どのような製薬会社にとっても、物流会社はその機能において非常に重要な役割を果たしています。その理由は、患者が緊急に医薬品を必要とするような重大かつ緊急な事態が発生した場合に、機器や医薬品を時間通りに届ける責任があるからです。このような状況では、一刻を争います。

医薬品ロジスティクスは、製薬企業にとって最も重要な業務のひとつであり、その活動は非常に時間的制約が大きいです。適切な薬を適切な患者に適切な時間、場所、用量で、そして最も重要なことは適切な価格で提供することが非常に重要なのです。

市場力学：促進要因と阻害要因

コールドチェーンロジスティクスの進歩の高まり

コールドチェーンロジスティクスの進歩は、予測期間中に市場を牽引する重要な要因のひとつです。コールドチェーンロジスティクスは、医薬品の有効性と安全性を維持するために、特定の温度範囲で医薬品を保管・輸送することを保証します。温度監視・制御技術の進歩は、温度逸脱を防ぎ、製品の腐敗リスクを低減するのに役立ちます。

例えば、2021年2月、サプライチェーン可視化プロバイダーの大手であるSensitech社は、IoTデバイスの製品群を拡張し、貨物が飛行機で移動する際に貨物をリアルタイムで追跡するための航空会社承認モデルや非リチウム電池モデルを追加しました。

強化されたTempTale GEOとVizComm Viewの製品ファミリーは、ワクチン、医薬品、検査キットなどの出荷を有効なデータでサポートし、貨物の移動方法（空路、陸路、海路）に関係なく、重要な受け入れ/拒否の意思決定を可能にします。センシテックは、健康的で安全かつ持続可能な建物とコールドチェーンソリューションの世界的大手プロバイダーであるCarrier Global Corporationの一員です。

さらに、医薬品セクターの成長、医薬品セクターにおけるリバースロジスティクス需要の増加、国際貿易活動の増加といった要因が、予測期間中の世界の医薬品ロジスティクス市場の成長を後押しすると予想されています。さらに、温度に敏感な医薬品の需要の増加や、医薬品ロジスティクスのためのRFID技術は、まもなく医薬品ロジスティクス業界にとって機会を創出すると予想されます。

市場力学：阻害要因

医薬品ロジスティクスと保管における標準化の欠如は、予測期間中の市場成長を妨げる要因の1つです。医薬品ロジスティクスと保管の需要は様々なソースから影響を受けますが、標準や認定がないことが市場に課題を投げかけています。このため、倉庫スペースの品質や柔軟性に懸念が生じ、業界の要件に適応するようメーカーへのプレッシャーが高まっています。

温度への対応や自動化機器への対応という点で、施設をアップグレードするのは一筋縄ではいきません。技術や製品の取り扱いについて従業員を訓練し、成長させるには、多額の財政支出が必要になります。その結果、医薬品ロジスティクスにおける標準化の欠如が、医薬品ロジスティクス市場の成長を制限すると予想されます。

目次

第1章 調査手法と調査範囲

第2章 定義と概要

第3章 エグゼクティブサマリー

第4章 市場力学

  • 影響要因
    • 促進要因
      • 技術進歩の高まり
      • 医薬品分野におけるリバースロジスティクス需要の増加
    • 抑制要因
      • 医薬品ロジスティクスと保管における標準化の欠如
    • 機会
    • 影響分析

第5章 産業分析

  • ポーターのファイブフォース分析
  • サプライチェーン分析
  • 価格分析
  • 規制分析
  • パイプライン分析
  • アンメットニーズ
  • DMI意見

第6章 COVID-19分析

第7章 サービスタイプ別

  • コールドチェーン物流
  • 非コールドチェーン物流

第8章 輸送形態別

  • 航空輸送
  • 水路
  • 道路
  • 鉄道

第9章 医薬品製品タイプ別

  • 医薬化学品
  • バイオ医薬品
  • 医薬品最終製品
  • その他

第10章 地域別

  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • ドイツ
    • 英国
    • フランス
    • イタリア
    • スペイン
    • その他欧州
  • 南米
    • ブラジル
    • アルゼンチン
    • その他南米
  • アジア太平洋地域
    • 中国
    • インド
    • 日本
    • オーストラリア
    • その他アジア太平洋地域
  • 中東・アフリカ

第11章 競合情勢

  • 競合シナリオ
  • 市況/シェア分析
  • M&A分析

第12章 企業プロファイル

  • AIT Worldwide Logistics, Inc
    • 会社概要
    • 製品ポートフォリオと説明
    • 財務概要
    • 主な発展
  • Yusen Logistics
  • Air Canada Cargo
  • CEVA Logistics SA
  • Continental Carriers Pvt Ltd
  • Deutsche Post AG
  • FedEx Corporation
  • Kerry Logistics Network Limited
  • AWL
  • Nippon Express Holdings

第13章 付録

目次
Product Code: PH1646

Overview

Pharmaceutical logistics deals with manufacturing, processing, shipping materials, and resources. It even deals with activities related to the handling of manufactured goods to their customers. For any Pharmaceutical company, the logistics companies play a very crucial role in its functioning. The reason is that they have the responsibility to deliver equipment and drugs on time as at times there are critical and emergencies where the patient needs it urgently. In such a situation every second counts.

Pharmaceutical logistics is one of the most important stages of the operations for any pharmaceutical business as the activities are highly time-sensitive. It is very critical to provide the right medicine to the right patient at the right time, place and dosage and most importantly at the right price.

Market Dynamics: Drivers and Restraints

Rise in advancements in cold chain logistics

Advancements in cold chain logistics are one of the significant factors that help the market to drive during the forecast period. Cold chain logistics ensures that pharmaceutical products are stored and transported at specific temperature ranges to maintain their efficacy and safety. Advancements in temperature monitoring and control technology help prevent temperature excursions, reducing the risk of product spoilage.

For instance, in February 2021, leading supply chain visibility provider Sensitech expanded its suite of IoT devices to include air-carrier-approved and non-lithium battery models for real-time tracking of shipments when cargo is traveling by plane.

The enhanced family of TempTale GEO and VizComm View products support shipments including vaccines, pharmaceuticals and test kits with validated data, enabling critical accept/reject decision-making, regardless of how cargo is moving - by air, land or sea. Sensitech is a part of Carrier Global Corporation, the leading global provider of healthy, safe and sustainable building and cold chain solutions.

Furthermore, factors such as growth in the pharmaceutical sector, increase in demand for reverse logistics in the pharmaceutical sector and increase in international trade activities are anticipated to boost the growth of the global pharmaceutical logistics market during the forecast period. Moreover, the rise in demand for temperature-sensitive pharmaceutical drugs, and RFID technologies for pharmaceutical logistics is expected to create an opportunity for the pharmaceutical logistics industry shortly.

Market Dynamics: Restraint

Lack of standardization in pharmaceutical logistics and storage is one of the factors that hamper the market growth during the forecast period. Pharmaceutical logistics and storage demand is influenced by various sources, but the absence of standards and accreditations poses challenges to the market. This leads to concerns about warehouse space quality and flexibility, and increased pressure on manufacturers to adapt to industry requirements.

It is not straightforward to upgrade the facility in terms of temperature compliance or accommodating automated equipment. Training and growing employees in technology and product handling require significant financial expenditure. As a result, the lack of standardization in pharmaceutical logistics is expected to restrict pharmaceutical logistics market growth.

Segment Analysis

The global pharmaceutical logistics market is segmented based on service type, mode of transport, pharmaceutical product type and region.

The cold chain logistics segment from the service type segment accounted for approximately 41.7% Pharmaceutical Logistics market share

The cold chain logistics segment from the service type segment accounted for approximately 41.7% and it is expected to be dominated during the forecast period. Cold chain logistics is the technology and process that allows for the safe transport of temperature-sensitive goods and products along the supply chain. It relies heavily on science to evaluate and accommodate the link between temperature and perishability. Any product is known to be labelled "perishable" will likely need cold chain management.

For instance, in March 2022, Lineage Logistics LLC, the world's largest and most innovative temperature-controlled industrial REIT and logistics solutions, acquired MTC Logistics, a leading cold-chain provider in four strategic locations on or near the ports of Baltimore, MD, Wilmington, DE, and Mobile, AL. These facilities will expand Lineage's current footprint, which already includes over 400 strategically positioned facilities with a combined capacity of over 2 billion cubic feet across 19 nations.

Moreover, in December 2020, A.P. Moller - Maersk has signed a three-year logistics agreement with Novo Nordisk, covering ocean services and inland logistics. The agreement aims to reduce the pharmaceutical company's carbon footprint in transportation by using sustainable biofuel to power selected Maersk vessels. The agreement demonstrates A.P. Moller-Maersk's rapid transformation into a modern end-to-end logistics company. The partnership also aligns with Novo Nordisk's ambitious sustainability goals, as it demonstrates the company's commitment to sustainability.

Geographical Analysis

North America accounted for approximately 38.4% of the market share in 2022

North America is estimated to hold about 38.4% of the total market share throughout the forecast period, owing to the increasing sales of generic drugs, as well as reforms in the healthcare sector favoring generics, several regional and international companies, collaborations with the key players and others help this region to have the highest market share during the forecast period.

For instance, in April 2023, MD Logistics, LLC, a group company of Japan-based Nippon Express Holdings, has opened Garner 2000 Pharmaceutical Logistics Centre, a dedicated pharmaceutical warehouse established in Garner, North Carolina in January this year.

North Carolina is a key hub for the pharmaceutical industry in the United States (US), with numerous major pharmaceutical manufacturers and life science companies having expanded into the state. It is also home to many research institutes and universities that have amassed significant medical knowledge and technologies.

COVID-19 Impact Analysis

COVID-19 had a substantial impact on the pharmaceutical logistics market where the COVID-19 pandemic has necessitated the need for temperature-sensitive storage facilities for vaccinations. Also, there was an high demand for temperature-sensitive proteins and nutritional supplements due to evolving consumer lifestyles and dietary habits.

Market Segmentation

Service Type

  • Cold Chain Logistics
  • Non-Cold Chain Logistics

Mode of Transport

  • Air
  • Water
  • Road
  • Rail

Pharmaceutical Product Type

  • Pharmaceutical Chemicals
  • Bio-Pharmaceuticals
  • Pharmaceutical end products
  • Others

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Rest of Europe
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • Rest of Asia-Pacific
  • Middle East and Africa

Competitive Landscape

major global players in the market include: AIT Worldwide Logistics, Inc., Yusen Logistics, Air Canada Cargo, CEVA Logistics SA, Continental Carriers Pvt Ltd, Deutsche Post AG, FedEx Corporation, Kerry Logistics Network Limited, AWL, Nippon Express Holdings and among others.

Key Developments

  • In November 2022, UPS acquired healthcare logistics provider Bomi Group to expand its temperature-controlled facilities. With this acquisition, the UPS Healthcare network in Europe and Latin America will gain access to temperature-controlled facilities in 14 countries and over 3,000 highly qualified Bomi Group team members.
  • In November 2020, Pharma Logistics and ConsortiEX, market leaders in serving the needs of pharmacies and hospitals, launched their new program which is focused on improving inventory efficiency strategic collaboration programs, reducing cost, improving patient safety, and managing cash flow and compliance for their customers.

Why Purchase the Report?

  • To visualize the global pharmaceutical logistics market segmentation based on service type, mode of transport, pharmaceutical product type and region as well as understand key commercial assets and players.
  • Identify commercial opportunities by analyzing trends and co-development.
  • Excel data sheet with numerous data points of pharmaceutical logistics market-level with all segments.
  • PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
  • Product mapping available as excel consisting of key products of all the major players.

The global pharmaceutical logistics market report would provide approximately 61 tables, 58 figures and 187 Pages.

Target Audience 2023

  • Manufacturers/ Buyers
  • Industry Investors/Investment Bankers
  • Research Professionals
  • Emerging Companies

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

  • 3.1. Snippet by Service Type
  • 3.2. Snippet by Mode of Transport
  • 3.3. Snippet by Pharmaceutical Product Type
  • 3.4. Snippet by Region

4. Market Dynamics

  • 4.1. Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Rise in the technological advancements
      • 4.1.1.2. Increase in demand for reverse logistics in the pharmaceutical sector
    • 4.1.2. Restraints
      • 4.1.2.1. Lack of standardization in pharmaceutical logistics and storage
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's Five Force Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Pricing Analysis
  • 5.4. Regulatory Analysis
  • 5.5. Pipeline Analysis
  • 5.6. Unmet Needs
  • 5.7. DMI Opinion

6. COVID-19 Analysis

  • 6.1. Analysis of COVID-19
    • 6.1.1. Scenario Before COVID
    • 6.1.2. Scenario During COVID
    • 6.1.3. Scenario Post COVID
  • 6.2. Pricing Dynamics Amid COVID-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During Pandemic
  • 6.5. Manufacturers Strategic Initiatives
  • 6.6. Conclusion

7. By Service Type

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Service Type
    • 7.1.2. Market Attractiveness Index, By Service Type
  • 7.2. Cold Chain Logistics *
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3. Non-Cold Chain Logistics

8. By Mode of Transport

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Mode of Transport
    • 8.1.2. Market Attractiveness Index, By Mode of Transport
  • 8.2. Air*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3. Water
  • 8.4. Road
  • 8.5. Rail

9. By Pharmaceutical Product Type

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Pharmaceutical Product Type
    • 9.1.2. Market Attractiveness Index, By Pharmaceutical Product Type
  • 9.2. Pharmaceutical Chemicals*
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 9.3. Bio-Pharmaceuticals
  • 9.4. Pharmaceutical end products
  • 9.5. Others

10. By Region

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 10.1.2. Market Attractiveness Index, By Region
  • 10.2. North America
    • 10.2.1. Introduction
    • 10.2.2. Key Region-Specific Dynamics
    • 10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Service Type
    • 10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Mode of Transport
    • 10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Pharmaceutical Product Type
    • 10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.2.6.1. U.S.
      • 10.2.6.2. Canada
      • 10.2.6.3. Mexico
  • 10.3. Europe
    • 10.3.1. Introduction
    • 10.3.2. Key Region-Specific Dynamics
    • 10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Service Type
    • 10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Mode of Transport
    • 10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Pharmaceutical Product Type
    • 10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.3.6.1. Germany
      • 10.3.6.2. UK
      • 10.3.6.3. France
      • 10.3.6.4. Italy
      • 10.3.6.5. Spain
      • 10.3.6.6. Rest of Europe
  • 10.4. South America
    • 10.4.1. Introduction
    • 10.4.2. Key Region-Specific Dynamics
    • 10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Service Type
    • 10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Mode of Transport
    • 10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Pharmaceutical Product Type
    • 10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.4.6.1. Brazil
      • 10.4.6.2. Argentina
      • 10.4.6.3. Rest of South America
  • 10.5. Asia-Pacific
    • 10.5.1. Introduction
    • 10.5.2. Market Size Analysis and Y-o-Y Growth Analysis (%), By Service Type
    • 10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Mode of Transport
    • 10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Pharmaceutical Product Type
    • 10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.5.5.1. China
      • 10.5.5.2. India
      • 10.5.5.3. Japan
      • 10.5.5.4. Australia
      • 10.5.5.5. Rest of Asia-Pacific
  • 10.6. Middle East and Africa
    • 10.6.1. Introduction
    • 10.6.2. Key Region-Specific Dynamics
    • 10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Service Type
    • 10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Mode of Transport
    • 10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Pharmaceutical Product Type

11. Competitive Landscape

  • 11.1. Competitive Scenario
  • 11.2. Market Positioning/Share Analysis
  • 11.3. Mergers and Acquisitions Analysis

12. Company Profiles

  • 12.1. AIT Worldwide Logistics, Inc *
    • 12.1.1. Company Overview
    • 12.1.2. Product Portfolio and Description
    • 12.1.3. Financial Overview
    • 12.1.4. Key Developments
  • 12.2. Yusen Logistics
  • 12.3. Air Canada Cargo
  • 12.4. CEVA Logistics SA
  • 12.5. Continental Carriers Pvt Ltd
  • 12.6. Deutsche Post AG
  • 12.7. FedEx Corporation
  • 12.8. Kerry Logistics Network Limited
  • 12.9. AWL
  • 12.10. Nippon Express Holdings

LIST NOT EXHAUSTIVE

13. Appendix

  • 13.1. About Us and Services
  • 13.2. Contact Us